Eric Cogo is a seasoned professional in the pharmaceutical industry with extensive experience in drug development and formulation. Since April 2015, Eric has served as VP of DMPK and Developability Assessment at Evotec in France, leading an integrated platform that combines various scientific expertise to support programs from lead identification to early development for small molecules. Prior to Evotec, Eric held multiple key positions at Sanofi from September 1996 to March 2015, including Head of the Physico-Chemistry, Early Drug Formulation, ADME, and PK unit in Toulouse, where responsibilities involved merging scientific capabilities to support preclinical profiling phases. Eric also played a vital role in the global harmonization of methodologies within the Analytical Sciences Platform and has a PhD in Organic Chemistry from the University of Toulouse.
This person is not in any teams
This person is not in any offices